GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Entheon Biomedical Corp (XCNQ:ENBI) » Definitions » Price-to-Owner-Earnings

Entheon Biomedical (XCNQ:ENBI) Price-to-Owner-Earnings : (As of Apr. 30, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Entheon Biomedical Price-to-Owner-Earnings?

As of today (2024-04-30), Entheon Biomedical's share price is C$0.16. Entheon Biomedical does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Entheon Biomedical's Price-to-Owner-Earnings or its related term are showing as below:


XCNQ:ENBI's Price-to-Owner-Earnings is not ranked *
in the Biotechnology industry.
Industry Median: 32.37
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-04-30), Entheon Biomedical's share price is C$0.16. Entheon Biomedical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Nov. 2023 was C$-0.05. Therefore, Entheon Biomedical's PE Ratio for today is At Loss.

As of today (2024-04-30), Entheon Biomedical's share price is C$0.16. Entheon Biomedical's EPS without NRI for the trailing twelve months (TTM) ended in was C$-0.05. Therefore, Entheon Biomedical's PE Ratio without NRI for today is At Loss.

During the past 7 years, Entheon Biomedical's highest PE Ratio without NRI was 10.94. The lowest was 0.00. And the median was 7.81.


Entheon Biomedical Price-to-Owner-Earnings Historical Data

The historical data trend for Entheon Biomedical's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Entheon Biomedical Price-to-Owner-Earnings Chart

Entheon Biomedical Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Nov21 Nov22 Nov23
Price-to-Owner-Earnings
Get a 7-Day Free Trial - - - - -

Entheon Biomedical Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Entheon Biomedical's Price-to-Owner-Earnings

For the Biotechnology subindustry, Entheon Biomedical's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Entheon Biomedical's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Entheon Biomedical's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Entheon Biomedical's Price-to-Owner-Earnings falls into.



Entheon Biomedical Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Entheon Biomedical's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=0.16/-0.08
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Entheon Biomedical  (XCNQ:ENBI) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Entheon Biomedical Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Entheon Biomedical's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Entheon Biomedical (XCNQ:ENBI) Business Description

Traded in Other Exchanges
Address
999 West Broadway Street, Suite 720, Vancouver, BC, CAN, V5Z 1K5
Entheon Biomedical Corp is a biotechnology research and development company committed to developing and commercializing a portfolio of safe and effective Dimethyltryptamine based psychedelic therapeutic products (DMT Products) for the purposes of treating addiction and substance use disorders. Entheon intends to generate revenue through the sale of its DMT Products to physicians, clinics, and licensed psychiatrists in the United States, certain countries in the European Union, and throughout Canada.

Entheon Biomedical (XCNQ:ENBI) Headlines

No Headlines